{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T12:10:08Z","timestamp":1683288608924},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1993,12,1]],"date-time":"1993-12-01T00:00:00Z","timestamp":754704000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1993,12]]},"DOI":"10.1007\/bf02245693","type":"journal-article","created":{"date-parts":[[2005,11,15]],"date-time":"2005-11-15T01:51:13Z","timestamp":1132019473000},"page":"167-171","source":"Crossref","is-referenced-by-count":2,"title":["The effect of chronic treatment with naltrindole, a selective \u03b4-opioid antagonist, on \u03bc-opioid receptor-mediated antinociception in diabetic mice"],"prefix":"10.1007","volume":"113","author":[{"given":"Junzo","family":"Kamei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuriko","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nagase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwa","family":"Misawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Kasuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02245693_CR1","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/00007890-199204000-00051","volume":"53","author":"K Arakawa","year":"1992","unstructured":"Arakawa K, Akami T, Okamoto M, Oka T, Nagase H, Matsumoto S (1992) The immunosuppressive effect of \u03b4-opioid receptor antagonist on rat renal allograft survival. Transplantation 53:951\u2013953","journal-title":"Transplantation"},{"key":"BF02245693_CR2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0091-3057(84)80044-1","volume":"21","author":"MT Bardo","year":"1984","unstructured":"Bardo MT, Miller JS, Risner ME (1984) Opiate receptor supersensitivity produced by chronic naloxone treatment: dissociation of morphine-induced antinociception and conditioned taste aversion. Pharmacol Biochem Behav 21:591\u2013597","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02245693_CR3","first-page":"77","volume":"21","author":"A Boyum","year":"1967","unstructured":"Boyum A (1967) Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 21:77\u2013107","journal-title":"Scand J Clin Lab Invest"},{"key":"BF02245693_CR4","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2337\/diab.36.10.1173","volume":"36","author":"DA Brase","year":"1987","unstructured":"Brase DA, Han TH, Dewey WL (1987) Effects of glucose and diabetes on binding of naloxone and dihydromorphine to opiate receptors in mouse brain. Diabetes 36:1173\u20131177","journal-title":"Diabetes"},{"key":"BF02245693_CR5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0008-8749(88)90208-0","volume":"116","author":"DJJ Carr","year":"1988","unstructured":"Carr DJJ, Kim C-H, De Costa B, Jacobson AE, Rice KC, Blalock JE (1988) Evidence for a \u03b4-class opioid receptor on cells of immune system. Cell Immunol 116:44\u201351","journal-title":"Cell Immunol"},{"key":"BF02245693_CR6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0014-2999(84)90470-9","volume":"97","author":"R Cotton","year":"1984","unstructured":"Cotton R, Giles MG, Miller L, Shaw JS, Timms D (1984) ICI-174864: a highly selective antagonist for the opioid \u03b4-receptor. Eur J Pharmacol 97:331\u2013332","journal-title":"Eur J Pharmacol"},{"key":"BF02245693_CR7","first-page":"74","volume":"72","author":"FE D'Amour","year":"1941","unstructured":"D'Amour FE, Smith DL (1941) A method for determining loss of pain sensation. J Pharmacol Exp Ther 72:74\u201379","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02245693_CR8","first-page":"435","volume":"175","author":"WL Dewey","year":"1970","unstructured":"Dewey WL, Harris LS, Howes JF, Nuite JA (1970) The effect of various neurochemical modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests. J Pharmacol Exp Ther 175:435\u2013442","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02245693_CR9","first-page":"265","volume":"36","author":"A Goldstein","year":"1989","unstructured":"Goldstein A, Naidu A (1989) Multiple opioid receptors: ligand selectivity profiles and binding site signatures. Mol Pharmacol 36:265\u2013272","journal-title":"Mol Pharmacol"},{"key":"BF02245693_CR10","first-page":"12","volume":"12","author":"TJ Haley","year":"1957","unstructured":"Haley TJ, McCormick WG (1957) Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol 12:12\u201315","journal-title":"Br J Pharmacol"},{"key":"BF02245693_CR11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0889-1591(89)90019-6","volume":"3","author":"FH Hucklebridge","year":"1989","unstructured":"Hucklebridge FH, Hudspith BN, Muhamed J, Lydyard PM, Brostoff J (1989) Methionine-enkephalin stimulates in vitro prolifiration of human peripheral lymphocytes via delta opioid receptors. Brian Behav Immun 3:183\u2013189","journal-title":"Brian Behav Immun"},{"key":"BF02245693_CR12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0162-3109(90)90043-E","volume":"19","author":"FH Hucklebridge","year":"1990","unstructured":"Hucklebridge FH, Hudspith BN, Lydyard PM, Brostoff J (1990) Stimulation of human peripheral lymphocytes by methionine enkephalin and \u03b4-selective opioid analogues. Immunopharmacology 19:87\u201391","journal-title":"Immunopharmacology"},{"key":"BF02245693_CR13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0006-8993(92)90655-S","volume":"571","author":"J Kamei","year":"1992","unstructured":"Kamei J, Ohhashi Y, Kawashima N, Kasuya Y (1992a) Streptozotocin-induced diabetes selectivity alters the potency of analgesia produced by \u03bc-opioid agonists, but not by \u03b4-and \u03ba-opioid agonists. Brain Res 571:199\u2013203","journal-title":"Brain Res"},{"key":"BF02245693_CR14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0006-8993(92)90619-K","volume":"576","author":"J Kamei","year":"1992","unstructured":"Kamei J, Kawashima N, Kasuya Y (1992b) Role of spleen or spleen products in the deficiency in morphine-induced analgesia in diabetic mice. Brain Res 576:139\u2013142","journal-title":"Brain Res"},{"key":"BF02245693_CR15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0006-8993(92)90942-3","volume":"580","author":"J Kamei","year":"1992","unstructured":"Kamei J, Kawashima N, Ohhashi Y, Kasuya Y (1992c) Effects of diabetes on stress-induced analgesia in mice. Brain Res 580:180\u2013184","journal-title":"Brain Res"},{"key":"BF02245693_CR16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0014-2999(92)90424-3","volume":"210","author":"J Kamei","year":"1992","unstructured":"Kamei J, Kawashima N, Kasuya Y (1992d) Naloxone-induced analgesia in diabetic mice. Eur J Pharmacol 210:339\u2013341","journal-title":"Eur J Pharmacol"},{"key":"BF02245693_CR17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0006-8993(92)91663-Y","volume":"592","author":"J Kamei","year":"1992","unstructured":"Kamei J, Kawashima N, Kasuya Y (1992e) Paradoxical analgesia produced by naloxone in diabetic mice is attributable to supersensitivity of \u03b4-opioid receptors. Brain Res 592:101\u2013105","journal-title":"Brain Res"},{"key":"BF02245693_CR18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0014-2999(78)90343-6","volume":"51","author":"RA Lahti","year":"1978","unstructured":"Lahti RA, Collins RJ (1978) Chronic naloxone results in a prolonged increase in opiate binding sites in brain. Eur J Pharmacol 51:185\u2013186","journal-title":"Eur J Pharmacol"},{"key":"BF02245693_CR19","doi-asserted-by":"crossref","first-page":"934","DOI":"10.4049\/jimmunol.136.3.934","volume":"136","author":"RN Mandler","year":"1986","unstructured":"Mandler RN, Biddison WE, Mandler R, Serrate SA (1986) \u03b2-Endorphin augments cytolytic activity and interferon production of the natural killer cells. J Immunol 136:934\u2013939","journal-title":"J Immunol"},{"key":"BF02245693_CR20","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/0024-3205(87)90711-9","volume":"41","author":"PJ McLaughlin","year":"1987","unstructured":"McLaughlin PJ, Zagon IS (1987) Modulation of human neuroblastoma transplanted into nude mice by endogenous opioid systems. Life Sci 41:1465\u20131472","journal-title":"Life Sci"},{"key":"BF02245693_CR21","first-page":"721","volume":"247","author":"MJ Millan","year":"1988","unstructured":"Millan MJ, Morris BJ, Herz A (1988) Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists. J Pharmacol Exp Ther 247:721\u2013728","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02245693_CR22","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/0090-1229(83)90131-9","volume":"26","author":"GC Miller","year":"1983","unstructured":"Miller GC, Murgo AJ, Plotnikoff NP (1983) Enkephalins: enhancement of active T-cell rosettes from lymphoma patients. Clin Immunol Immunopathol 26:446\u2013451","journal-title":"Clin Immunol Immunopathol"},{"key":"BF02245693_CR23","first-page":"729","volume":"247","author":"BJ Morris","year":"1988","unstructured":"Morris BJ, Millan MJ, Herz A (1988) Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography. J Pharmacol Exp Ther 247:729\u2013736","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02245693_CR24","first-page":"341","volume":"75","author":"AJ Murgo","year":"1985","unstructured":"Murgo AJ (1985) Inhibition of B16-BL6 melanoma growth in mice by methionine-enkephalin. J Natl Cancer Inst 75:341\u2013344","journal-title":"J Natl Cancer Inst"},{"key":"BF02245693_CR25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0192-0561(83)90020-6","volume":"5","author":"NP Plotnikoff","year":"1983","unstructured":"Plotnikoff NP, Miller GC (1983) Enkephalin as immunomodulators. Int J Immunopharmacol 5:437\u2013441","journal-title":"Int J Immunopharmacol"},{"key":"BF02245693_CR26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/jm00397a001","volume":"31","author":"PS Portoghese","year":"1988","unstructured":"Portoghese PS, Sultana M, Nagase H, Takemori AE (1988) Application of the message-address concept in the design of highly potent and selective non-peptide opioid receptor antagonists. J Med Chem 31:281\u2013282","journal-title":"J Med Chem"},{"key":"BF02245693_CR27","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1021\/jm00101a009","volume":"35","author":"PS Portoghese","year":"1992","unstructured":"Portoghese PS, Larson DL, Sultana M, Takemori AE (1992) Opioid agonist and antagonist activities of morphindoles related to naltrindole. J Med Chem 35:4325\u20134329","journal-title":"J Med Chem"},{"key":"BF02245693_CR28","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/0024-3205(88)90554-1","volume":"42","author":"RB Raffa","year":"1988","unstructured":"Raffa RB, Kimball ES, Mathiasen JR (1988) The analgesic defect of C57BL\/6J-bgJ\/bgJ (beige-J; Chediak-Higashi syndrome) mice transmitted by adoptive transfer of spleen cells to normal littermates. Life Sci 42:1231\u20131236","journal-title":"Life Sci"},{"key":"BF02245693_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0024-3205(93)90281-7","volume":"52","author":"RB Raffa","year":"1993","unstructured":"Raffa RB, Mathiasen JR, Kimball ES, Vaught JL (1993) The combined immunological and antinociceptive defects of beige-J mice: the possible existence of a \u2018\u03bc-repressin\u2019. Life Sci 52:1\u20138","journal-title":"Life Sci"},{"key":"BF02245693_CR30","first-page":"676","volume":"257","author":"M Sofuoglu","year":"1991","unstructured":"Sofuoglu M, Portoghese PS, Takemori AE (1991) Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes. J Pharmacol Exp Ther 257:676\u2013680","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02245693_CR31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0014-2999(90)90481-K","volume":"178","author":"T Suzuki","year":"1990","unstructured":"Suzuki T, Fukagawa Y, Misawa M (1990) Enhancement of morphine withdrawal signs in the rat after chronic treatment with naloxone. Eur J Pharmacol 178:239\u2013242","journal-title":"Eur J Pharmacol"},{"key":"BF02245693_CR32","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0014-2999(78)90131-0","volume":"47","author":"AH Tang","year":"1978","unstructured":"Tang AH, Collins RJ (1978) Enhanced analgesic effects of morphine after chronic administration of naloxone in the rat. Eur J Pharmacol 47:473\u2013474","journal-title":"Eur J Pharmacol"},{"key":"BF02245693_CR33","first-page":"439","volume":"232","author":"A Tempel","year":"1985","unstructured":"Tempel A, Gardner EL, Zukin RS (1985) Neurochemical and functional correlates of naltrexone-induced opiate receptor up-regulation. J Pharmacol Exp Ther 232:439\u2013444","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02245693_CR34","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.4049\/jimmunol.132.6.3046","volume":"132","author":"EDE Van","year":"1984","unstructured":"Van EDE, Salad L (1984) \u03b2-Endorphin and Met-enkephalin stimulate human peripheral blood mononuclear cell chemotaxis. J Immunol 132:3046\u20133053","journal-title":"J Immunol"},{"key":"BF02245693_CR35","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4049\/jimmunol.123.3.1068","volume":"123","author":"J Wybran","year":"1979","unstructured":"Wybran J, Appelboom T, Famaey JP, Govaerts A (1979) Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J Immunol 123:1068\u20131070","journal-title":"J Immunol"},{"key":"BF02245693_CR36","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1016\/0024-3205(85)90322-4","volume":"36","author":"BC Yoburn","year":"1985","unstructured":"Yoburn BC, Goodman RR, Cohen AH, Pasternak GW, Inturrisi CE (1985) Increased analgesic potency of morphine and increased brain opioid binding sites in the rat following chronic naltrexone treatment. Life Sci 36:2325\u20132332","journal-title":"Life Sci"},{"key":"BF02245693_CR37","first-page":"132","volume":"239","author":"BC Yoburn","year":"1986","unstructured":"Yoburn BC, Nunes FA, Adler B, Pasternak GW, Inturrisi CE (1986) Pharmacodynamic supersensitivity and opioid receptor upregulation in the mouse. J Pharmacol Exp Ther 239:132\u2013135","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02245693_CR38","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0024-3205(88)90587-5","volume":"43","author":"BC Yoburn","year":"1988","unstructured":"Yoburn BC. Luke MC, Pasternak GW, Inturrisi CE (1988) Upregulation of opioid receptor subtypes correlates with potency changes of morphine and DADLE. Life Sci 43:1319\u20131324","journal-title":"Life Sci"},{"key":"BF02245693_CR39","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/0006-2952(86)90314-X","volume":"35","author":"RS Zukin","year":"1986","unstructured":"Zukin RS, Tempel A (1986) Neurochemical correlates of opiates receptor upregulation. Biochem Pharmacol 35:1623\u20131627","journal-title":"Biochem Pharmacol"},{"key":"BF02245693_CR40","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0006-8993(82)90811-3","volume":"245","author":"RS Zukin","year":"1982","unstructured":"Zukin RS, Sugarman JR, Fitz-Syage ML, Gardner EL, Zukin SR, Gintzler AR (1982) Naltrexone-induced opiate receptor supersensitivity. Brain Res 245:285\u2013292","journal-title":"Brain Res"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02245693.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02245693\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02245693","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T11:54:30Z","timestamp":1683287670000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02245693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,12]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1993,12]]}},"alternative-id":["BF02245693"],"URL":"https:\/\/doi.org\/10.1007\/bf02245693","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,12]]}}}